CRISPR Therapeutics AG (CRSP) Current Leases (2019 - 2026)
CRISPR Therapeutics AG (CRSP) posted Current Leases of $18.6 million for Q1 2026, little changed sequentially from $18.6 million in Q4 2025, and up 6.32% YoY from $17.5 million in Q1 2025.
CRISPR Therapeutics AG (CRSP) Current Leases (2019 - 2026) Analysis & Trends
CRISPR Therapeutics AG has reported Current Leases for 8 years, with the latest figure at $18.6 million in Q1 2026.
- Quarterly Current Leases rose 6.32% year-over-year to $18.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $18.6 million (up 6.32% YoY) and the FY2025 annual result came in at $18.6 million, up 7.46% from the prior year.
- Current Leases steadied at $18.6 million in Q1 2026 per CRSP's latest filing, from $18.6 million in the prior quarter.
- Over five years, Current Leases peaked at $18.6 million in Q1 2026 and troughed at $8.3 million in Q2 2022.
- A 5-year average of $15.6 million and a median of $16.0 million in 2024 frame the typical range for Current Leases.
- The sharpest annual moves came in 2022 and 2023: Current Leases sank 47.92% in 2022, then surged 79.42% in 2023.
- Over 5 years, Current Leases stood at $15.8 million in 2022, then dropped by 1.37% to $15.6 million in 2023, then advanced by 10.64% to $17.3 million in 2024, then rose by 7.46% to $18.6 million in 2025, then increased by 0.18% to $18.6 million in 2026.
- According to Business Quant data, Current Leases over the past three periods registered $18.6 million, $18.6 million, and $18.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 720.00 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 11.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 16.75 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 21.95 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 2.24 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 45.93 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 6.27 Mn |
| 10 | CRISPR Therapeutics AG | 5.18 Bn | 5.18 Bn | - | 18.65 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 18.65 Mn |
| Mar 31, 2026 | 18.61 Mn |
| Dec 31, 2025 | 18.58 Mn |
| Sep 30, 2025 | 18.26 Mn |
| Jun 30, 2025 | 18.03 Mn |
| Mar 31, 2025 | 17.51 Mn |
| Dec 31, 2024 | 17.29 Mn |
| Sep 30, 2024 | 16.88 Mn |
| Jun 30, 2024 | 16.45 Mn |
| Mar 31, 2024 | 15.99 Mn |
| Dec 31, 2023 | 15.63 Mn |
| Sep 30, 2023 | 15.00 Mn |
| Jun 30, 2023 | 14.83 Mn |
| Mar 31, 2023 | 15.72 Mn |
| Dec 31, 2022 | 15.84 Mn |
| Sep 30, 2022 | 11.26 Mn |
| Jun 30, 2022 | 8.27 Mn |
| Mar 31, 2022 | 11.08 Mn |
| Dec 31, 2021 | 12.16 Mn |
| Sep 30, 2021 | 12.64 Mn |